Skip to Main Content

Author Details

Michael A Gillette
1995
55
33
PMIDPaper TitleJournal TitlePublished Year
37012232Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues.Nat Commun2023
36004393Perioperative Antiplatelet Bridging With Cangrelor: A Cohort Study and Narrative Review.Annals of Pharmacotherapy2023
36707610LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma.Sci Rep2023
35236940Cancer proteogenomics: current impact and future prospects.Nat Rev Cancer2022
36001024Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer.Cancer Discov2022
34591593Genomic Profiling of Lung Adenocarcinoma in Never-Smokers.J Clin Oncol2021
33534888Biomarkers to Distinguish Bacterial From Viral Pediatric Clinical Pneumonia in a Malaria-Endemic Setting.Clin Infect Dis2021
33038391Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza: A Systematic Review.Chest2021
33111533Ins and Outs: Perspectives of Inpatient Prescribing for Sacubitril/Valsartan.Annals of Pharmacotherapy2021
33417831Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.Cancer Cell2021
34569154A highly multiplexed quantitative phosphosite assay for biology and preclinical studies.Mol Syst Biol2021
34317411Acute Tubular Injury in a Patient on a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor.JACC Case Rep2020
32318933Reflections of the Angiotensin Receptor Blocker Recall by the FDA and Repercussions on Healthcare.Cardiovasc Drugs Ther2020
30576842Improving anti-platelet therapy adherence in the Veterans Health Administration: A randomized multi-site hybrid effectiveness-implementation study protocol.Contemp Clin Trials2019
31645455A rapid triage test for active pulmonary tuberculosis in adult patients with persistent cough.Sci Transl Med2019
29472518Mass Spectrometry-Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers.Cancer Res2018
30205044Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups.Cancer Cell2018
29988108Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry.Nat Protoc2018
27837008Transcriptional Categorization of the Etiology of Pneumonia Syndrome in Pediatric Patients in Malaria-Endemic Areas.J Infect Dis2017
28348404Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.Nat Commun2017
28804679Time to Neurological Deterioration in Ischemic Stroke.2017
28749931Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry.Nat Protoc2017
28440318Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.Nat Commun2017
26469764Responses to Bacteria, Virus, and Malaria Distinguish the Etiology of Pediatric Clinical Pneumonia.Am J Respir Crit Care Med2016
27251275Proteogenomics connects somatic mutations to signalling in breast cancer.Nature2016
27139709Antiplatelet Management for Coronary Heart Disease: Advances and Challenges.Curr Atheroscler Rep2016
26071828Implications for Ezetimibe Therapy Use Based on IMPROVE-IT Criteria.Am J Med2015
25724909Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury.Mol Cell Proteomics2015
25944803Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array.Clin Cancer Res2015
26582305Unfractionated heparin anticoagulation using estimated blood volume based dosing versus weight-based dosing in a Veteran population.American Journal of Health-System Pharmacy2015
24784010Persistent leukocytosis-is this a persistent problem for patients with acute ischemic stroke?J Stroke Cerebrovasc Dis2014
24719451Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.Mol Cell Proteomics2014
25182330Dolutegravir: a new integrase strand transfer inhibitor for the treatment of HIV - an alternative viewpoint.Pharmacotherapy2014
24522978Simplified and efficient quantification of low-abundance proteins at very high multiplex via targeted mass spectrometry.Mol Cell Proteomics2014
23246190Identification of modifiable and nonmodifiable risk factors for neurologic deterioration after acute ischemic stroke.J Stroke Cerebrovasc Dis2013
22727922What change in the National Institutes of Health Stroke Scale should define neurologic deterioration in acute ischemic stroke?Journal of Stroke and Cerebrovascular Diseases2013
24124232Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium.Cancer Discov2013
24063748Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies.J Proteome Res2013
23749302Integrated proteomic analysis of post-translational modifications by serial enrichment.Nat Methods2013
23269374Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry.Nat Methods2013
23031742Leukocytosis in patients with neurologic deterioration after acute ischemic stroke is associated with poor outcomes.Journal of Stroke and Cerebrovascular Diseases2013
22215689Clinical experience with ranolazine in a veteran population with chronic stable angina.Annals of Pharmacotherapy2012
21685905A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease.Nat Biotechnol2011
19131327A human proteome detection and quantitation project.Mol Cell Proteomics2009
18534968Accurate inclusion mass screening: a bridge from unbiased discovery to targeted assay development for biomarker verification.Mol Cell Proteomics2008
17389406Metagene projection for cross-platform, cross-species characterization of global transcriptional states.Proc Natl Acad Sci U S A2007
16900146Protein biomarker discovery and validation: the long and uncertain path to clinical utility.Nat Biotechnol2006
16857664PEPPeR, a platform for experimental proteomic pattern recognition.Mol Cell Proteomics2006
16199517Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.Proc Natl Acad Sci U S A2005
16083265Place of pattern in proteomic biomarker discovery.J Proteome Res2005
  • 1 - 50 of 55

Recommended Authors

Collaborators

Broad Institute of MIT and Harvard
Co-authored papers 31
Co-authored papers 19
Co-authored papers 13
Co-authored papers 9
Co-authored papers 9
Co-authored papers 8
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 7
Co-authored papers 7
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Co-authored papers 7
Co-authored papers 7
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
Institute for Systems Genetics, NYU Grossman School of Medicine
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
University of California San Diego
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Baylor College of Medicine
Co-authored papers 4
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
University of California San Diego
Co-authored papers 3
Co-authored papers 3